Method and apparatus for treatment of adipose tissue

• US 9,314,650 B2
• Filed: 02/09/2012
• Issued: 04/19/2016
• Est. Priority Date: 02/16/2006
• Status: Active Grant

• Current Assignee: Syneron Medical Limited (Syneron Incorporated)
• Original Assignee: Syneron Medical Limited (Syneron Incorporated)
• Inventors: Rosenberg, Avner, Eckhouse, Shimon, Kreindel, Michael
• Primary Examiner(s): Peng, Bo J
• Application Number:
  US13/369,583
• Publication Number:
  US 20120136280A1
• Time in Patent Office: 1,531 Days
• US Class Current: 1/1
• CPC Class Codes: A61B 18/12 by passing a current through the tissue to be heated, e.g. high-frequency current
• CPC Class Codes: A61B 2017/00026 Conductivity or impedance, e.g. of tissue
• CPC Class Codes: A61B 2017/00061 spectrum
• CPC Class Codes: A61B 2017/00106 ultrasonic
• CPC Class Codes: A61B 2018/0047 Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
• CPC Class Codes: A61B 2090/378 using ultrasound
• CPC Class Codes: A61N 1/0408 Use-related aspects
• CPC Class Codes: A61N 1/0472 Structure-related aspects
• CPC Class Codes: A61N 1/328 for improving the appearance of the skin, e.g. facial toning or wrinkle treatment
• CPC Class Codes: A61N 2007/0008 Destruction of fat cells
• CPC Class Codes: A61N 2007/0039 using microbubbles
• CPC Class Codes: A61N 2007/0078 with multiple treatment transducers
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

The invention provides methods and apparatuses for the treatment of adipose tissue. The methods comprise application of ultrasound energy to a region of adipose tissue, and the apparatuses comprise at least one source of ultrasound energy configured to direct ultrasound energy through a skin surface into the subcutaneous adipose tissue. In one embodiment, a pressure gradient is created in the region generating relative movement between fat cell constituents having different densities. In another embodiment, a protrusion of skin and underlying adipose tissue containing is formed and ultrasound energy is radiated into the adipose tissue in the protrusion. In another embodiment, an RF electric field is generated inside a region of adipose tissue together with the ultrasound energy.

Claims

1. An applicator for selective treatment of adipose tissue, the applicator comprising:

a hollow dome comprising an interior chamber communicating through a port with a vacuum pump, the hollow dome configured to be applied to a skin to suction the skin and a subcutaneous tissue into the interior chamber, forming a protrusion protruding above a surrounding surface of the skin, the protrusion including an adipose tissue;

one or more moderately focused ultrasound transducers located in the interior chamber of the hollow dome generating ultrasound energy with focal volumes located in the protrusion of the adipose tissue, and generating a power flow density of the ultrasound energy lower than the threshold for cavitation in the adipose tissue being treated, however sufficient to generate pressure gradients in the focal volumes;

a pair of radio frequency (RF) electrodes located at sides of the hollow dome and electrically isolated from the hollow dome and the one or more moderately focused ultrasound transducers, the RF electrodes driven by an RF driver operative to provide RF energy to the RF electrodes such that when both the RF electrodes are in contact with the skin the RF energy creates a high electric field in the adipose tissue, wherein the RF electrodes comprising a thin film of electrically conducting material having negligible ultrasound attenuation applied to each face of the one or more moderately focused ultrasound transducers when both the RF electrodes touch the skin; and

a cavitation sensor comprising a receiver tuned to half the moderately focused ultrasound transmitting frequency, the receiver configured to detect and control an appearance of cavitation in the tissue being treated and control a pressure level such that the pressure level does not cause cavitation in lipid, cytoplasm, and intercellular fluids of the tissue being treated.

2. The applicator according to claim 1, wherein regions of maximum electric field and ultrasound focal volumes at least partially overlap within the adipose tissue, to maximize a combined effects of simultaneously applied the RF energy and the ultrasound energy.

3. The applicator according to claim 1, wherein the one or more moderately focused ultrasound transducers emit ultrasound that heats the adipose tissue in the focal volumes and increases the RF conductivity such that more energy is delivered by the RF energy into the same heated focal volumes yielding a combined stress and reducing a cell strength of the adipose tissue.

4. The applicator according to claim 3, wherein a temperature of the heated focal volumes is kept below 44 degrees Celsius.

5. The applicator according to claim 1, wherein the electric field created in the adipose tissue heats minority fluids in the adipose tissue and generates additional strain on cell membranes of the adipose tissue.

6. The applicator according to claim 1, wherein the one or more moderately focused ultrasound transducers are one of a group of transducers consisting of flat transducers, curved transducers or transducers with a lens.

7. The applicator according to claim 6, wherein the one or more moderately focused ultrasound transducers are phased array transducers and wherein phases of the array transducers are controlled, and matched in a way that maximizes the ultrasound intensity in the focal volumes and the pressure gradients in the focal volumes.

8. The applicator according to claim 1, wherein the one or more moderately focused ultrasound transducers in the interior chamber are oriented so that the direction of ultrasound radiation from the transducers is parallel to surface of the skin outside the protrusion in order to avoid penetration of ultrasound energy to internal tissues and organs below the adipose tissue.

9. The applicator according to claim 1, wherein the one or more moderately focused transducers provide moderately focused ultrasound energy confined to a view angle of less than 120 degrees for selective treatment of adipose tissue.

10. The applicator according to claim 1, wherein the one or more moderately focused transducer provide moderately focused ultrasound energy confined to a view angle of less than 90 degrees for selective treatment of adipose tissue.

11. The applicator according to claim 1, wherein the one or more moderately focused ultrasound transducers generate a pressure gradient between 2 GPa/m to 15 GPa/im and the ultrasound energy has a frequency lower than 1 MHz.

12. The applicator according to claim 1, wherein the ultrasound energy is monitored by measuring an electrical impedance of the one or more moderately focused ultrasound transducer, and variations in power transmission from the one or more moderately focused ultrasound transducer are manifested by changes in a voltage-current relation on the one or more moderately focused ultrasound transducer.

13. The applicator according to claim 1, wherein the pressure gradients generate a relative movement between fat cell constituents having different densities.

14. The applicator according to claim 1, wherein the RF electrodes, are one of a group of electrodes consisting of conductive electrodes for direct injection of current to the skin, and electrodes insulated by a thin layer of insulating material for capacitive coupling of energy to the adipose tissue.

15. The applicator according to claim 1, further comprising a processor for monitoring a contact between the RF electrodes and the skin is done by measuring a voltage across the RF electrodes and a current, and calculating from the voltage and the current an impedance between the RF electrodes, and monitoring a coupling of the one or more moderately focused ultrasound transducers to the skin by measuring a transducer impedance.

16. The applicator according to claim 1, wherein the one or more moderately focused ultrasound transducers enhance pressure gradient at an expense of pressure amplitude at the focal volumes and obtain selective treatment of the adipose tissue without cavitation.

17. The applicator according to claim 1, wherein the power flow density is at 700 W/cm2 or below.

18. An applicator for selective treatment of adipose tissue, the applicator comprising:

a hollow dome comprising an interior chamber communicating through a port with a vacuum pump, the hollow dome configured to be applied to a skin to suction the skin and a subcutaneous tissue into the interior chamber, forming a protrusion protruding above a surrounding surface of the skin, the protrusion including an adipose tissue;

one or more moderately focused ultrasound transducers located in the interior chamber of the hollow dome and generating ultrasound energy with focal volumes located in the protrusion of the adipose tissue, the one or more moderately focused ultrasound transducers, generating a power flow density of the ultrasound energy lower than a threshold for cavitation, however, sufficient to, generate pressure, gradients in the focal volumes in the adipose tissue being treated;

a pair of radio frequency (RF) electrodes located at sides of the hollow dome and electrically isolated from the hollow dome and the one or more moderately focused ultrasound transducers, the RF electrodes driven by an RF driver operative to provide RF energy to the RF electrodes such that when both the RF electrodes are in contact with the skin the RF energy creates a high electric field in the adipose tissue, the RF electrodes comprising a thin film of electrically conducting material having negligible ultrasound attenuation applied to each face of the one or more moderately focused ultrasound transducers when both the RF electrodes touch the skin, and

a cavitation sensor comprising a receiver tuned to half the moderately focused ultrasound transmitting frequency, the receiver configured to detect and control an appearance of cavitation in the tissue being treated and control a pressure level such that the pressure level does not cause cavitation in lipid, cytoplasm and intercellular fluids of the tissue being treated.